Últimas noticias sobre Aadi Bioscience (NASDAQ:AADI) Bolsa

Aadi Bioscience

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience Inc

Aadi Bioscience (AADI – Research Report) received a Hold rating and price target from TD Cowen analyst Tara Bancroft yesterday. The company's share...

TD Cowen downgrades Aadi Bioscience (AADI) to a Hold

H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on AADI stock, giving a Hold rating yesterday. Robert Burns has given his ...

Aadi Bioscience: Hold Rating Amidst Trial Discontinuation and Limited Growth Prospects

Aadi Bioscience cut to hold at Jefferies following Fyarro failure in solid tumors

Aadi Bioscience (AADI) has provided an update. Loretta Itri, M.D., is stepping down as Chief Medical Officer but will receive a generous severance ...

Aadi Bioscience Executives Transition with Continued Roles

In a report released today, Joseph Catanzaro from Piper Sandler downgraded Aadi Bioscience (AADI – Research Report) to a Hold, with a price target ...

Hold Rating for Aadi Bioscience Amid Clinical Setbacks and Modest Revenue Projections

Aadi Bioscience downgraded to Neutral, shares fall

Aadi Bioscience ( ($AADI) ) has provided an update. Aadi Bioscience, Inc. has initiated a retention bonus program to incentivize its key employees,...

Aadi Bioscience Launches Executive Retention Bonus Program

Aadi Bioscience GAAP EPS of -$0.46 in-line, revenue of $7.21M beats by $0.61M

Aadi Bioscience, Inc. ( ($AADI) ) has released its Q3 earnings. Here is a breakdown of the information Aadi Bioscience, Inc. presented to its inves...

Aadi Bioscience Reports Q3 2024 Earnings and Growth

Aadi Bioscience, Inc. (AADI) has disclosed a new risk, in the Litigation & Legal Liabilities category. Aadi Bioscience, Inc. faces the risk of beco...

Aadi Bioscience Faces Potential Financial Strain from Securities Class Action Risks

AADI

Press Releases

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

Earnings

Small Cap

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Achilles Therapeutics plc - American Depositary Shares

Achilles Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

BioVie

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Celularity

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Elicio Therapeutics

Immuneering Corporation - Class A Common Stock

Immuneering

IO Biotech

Kronos Bio

Kezar Life Sciences

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

MAIA Biotechnology

Mural Oncology

OncoCyte

Omega Therapeutics

OS Therapies

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

RAPT Therapeutics

Protara Therapeutics, Inc. - Common Stock

Comments

Aadi Bioscience

Noticias

Últimas noticias sobre Aadi Bioscience (NASDAQ:AADI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL